The lab will allow for faster cancer biopsy results, which previously took weeks thanks to shipping times.
“We are now able to test for far more genetic mutations, allowing us to target therapies for patients’ cancers,” Charles Myers, MD, a pathologist and director of Norton Cancer Institute Genomics Lab, said in the release.
The lab can test for mutations in more than 50 genes; previously, Norton’s facilities could test for mutations in only three.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
